1992. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Critical Care Medicine, 20, 864– 874.
Abraham E., Laterre P.F., et al. (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. New England Journal of Medicine, 353, 1332–1341.
Bone R.C., Balk R.A., et al. (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest, 101, 1644–1655.
Booth F.V., Short M., et al. (2005) Application of a population-based severity scoring system to individual patients results in frequent misclassification. Critical Care, 9, R522–R529.
Brauner J.S., Rohde L.E., et al. (2000) Circulating endothelin-1 and tumor necro- sis factor-alpha: Early predictors of mortality in patients with septic shock. Intensive Care Medicine, 26, 305–313.
Christ-Crain M., Morgenthaler NG., et al. (2005) Mid-regional proadrenomedullin as a prognostic marker in sepsis: An observational study. Critical Care, 9(6), R816–R824.
Christ-Crain M., Morgenthaler N.G., et al. (2006). Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [IS- RCTN04176397]. Critical Care, 10, R96.
Eto T. (2001) A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides. Peptides, 22, 1693–1711.
Grandel U., and Grimminger F. (2003) Endothelial responses to bacterial toxins in sepsis. Critical Reviews in Immunology, 23, 267–299.
Hinson J.P., Kapas S., et al. (2000) Adrenomedullin, a multifunctional regulatory peptide. Endocrinological Reviews, 21, 138–167.
Kedzierski R.M., and Yanagisawa M. (2001) Endothelin system: The double- edged sword in health and disease. Annual Reviews in Pharmacology and Toxicology, 41, 851–876.
Landry D.W., and Oliver J.A. (2004) Insights into shock. Scientific America, 290, 36–41.
Levin E.R. (1995) Endothelins. New England Journal of Medicine, 333, 356– 363.
Morgenthaler N.G., Struck J., et al. (2005) Measurement of midregional proadrenomedullin in plasma with an immunoluminometric assay. Clinical Chemistry, 51, 1823–1829.
Muller B., Becker K.L., et al. (2000a) Disordered calcium homeostasis of sepsis: Association with calcitonin precursors. European Journal of Clinical Inves- tigation, 30, 823–831.
Muller B., Becker K.L., et al. (2000b) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Critical Care Medicine, 28, 977–983.
Muller B., Peri G., et al. (2001) Circulating levels of the long pentraxin PTX3 correlate with severity of infection in critically ill patients. Critical Care Medicine 29, 1404–1407.
Muller B., Peri G., et al. (2002) High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: Association of high decoy receptor levels with glucocorticoid administration. Journal of Leukocyte Biology, 72, 643–649.
Papassotiriou J., Morgenthaler N.G., et al. (2006) Immunoluminometric assay for measurement of the C-terminal endothelin-1 precursor fragment in human plasma. Clinical Chemistry, 52, 1144–1151.
Parrillo J.E. (2005) Severe sepsis and therapy with activated protein C. New England Journal of Medicine, 353, 1398–1400.
Peters K., Unger R.E., et al. (2003) Molecular basis of endothelial dysfunction in sepsis. Cardiovascular Research, 60, 49–57.
Pittet J.F., Morel D.R., et al. (1991) Elevated plasma endothelin-1 concentrations are associated with the severity of illness in patients with sepsis. Annals of Surgery, 213, 261–264.
Polderman K.H., Girbes A.R., et al. (2001) Accuracy and reliability of APACHE II scoring in two intensive care units: Problems and pitfalls in the use of APACHE II and suggestions for improvement. Anaesthesia, 56, 47–50.
Rongen G.A., Smits P., et al. (1994) Endothelium and the regulation of vascular tone with emphasis on the role of nitric oxide. Physiology, pathophysi- ology and clinical implications. Netherlands Journal of Medicine, 44, 26– 35.
Struck J., Morgenthaler N.G., et al. (2005) Proteolytic processing pattern of the endothelin-1 precursor in vivo. Peptides, 25, 1369–1372.
Struck J., Tao C., et al. (2004) Identification of an adrenomedullin precursor fragment in plasma of sepsis patients. Peptides, 25, 1369–1372.
Tschaikowsky K., Sagner S., et al. (2000) Endothelin in septic patients: Effects on cardiovascular and renal function and its relationship to proinflammatory cytokines. Critical Care Medicine, 28, 1854–1860.
Ueda S., Nishio K., et al. (1999) Increased plasma levels of adrenomedullin in patients with systemic inflammatory response syndrome. American Journal of Respiratory and Critical Care Medicine, 160, 132–136.
Wagner D.P., Draper E.A., Abizanda Campos R., Nikki P., Le Gall J.R., Loirat P., and Knaus W.A. (1984) Initial international use of APACHE. An acute severity of disease measure. Med Decis Making.
Weitzberg E., Lundberg J.M., et al. (1991) Elevated plasma levels of endothelin in patients with sepsis syndrome. Circulatory Shock, 33, 222–227.